These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 37375785)
1. Intracellular Drug Delivery Process of Am80-Encapsulated Lipid Nanoparticles Aiming for Alveolar Regeneration. Akita T; Oda K; Narukawa S; Morita Y; Tange K; Nakai Y; Yamashita C Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375785 [TBL] [Abstract][Full Text] [Related]
2. Am80-Encapsulated Lipid Nanoparticles, Developed with the Aim of Achieving Alveolar Regeneration, Have an Improvement Effect on Pulmonary Emphysema. Akita T; Morita Y; Kawai T; Oda K; Tange K; Nakai Y; Yamashita C Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678666 [TBL] [Abstract][Full Text] [Related]
4. Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease-Like Pathophysiology. Sakai H; Horiguchi M; Akita T; Ozawa C; Hirokawa M; Oiso Y; Kumagai H; Takeda Y; Tachibana I; Maeda N; Yamashita C J Pharmacol Exp Ther; 2017 Jun; 361(3):501-505. PubMed ID: 28432078 [TBL] [Abstract][Full Text] [Related]
5. The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA. Nkongolo S; Nußbaum L; Lempp FA; Wodrich H; Urban S; Ni Y Antiviral Res; 2019 Aug; 168():146-155. PubMed ID: 31018112 [TBL] [Abstract][Full Text] [Related]
6. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease. Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary administration of integrin-nanoparticles regenerates collapsed alveoli. Horiguchi M; Kojima H; Sakai H; Kubo H; Yamashita C J Control Release; 2014 Aug; 187():167-74. PubMed ID: 24954410 [TBL] [Abstract][Full Text] [Related]
8. Tamibarotene: a candidate retinoid drug for Alzheimer's disease. Fukasawa H; Nakagomi M; Yamagata N; Katsuki H; Kawahara K; Kitaoka K; Miki T; Shudo K Biol Pharm Bull; 2012; 35(8):1206-12. PubMed ID: 22863914 [TBL] [Abstract][Full Text] [Related]
9. Tamibarotene modulates the local immune response in experimental periodontitis. Jin Y; Wang L; Liu D; Lin X Int Immunopharmacol; 2014 Dec; 23(2):537-45. PubMed ID: 25448496 [TBL] [Abstract][Full Text] [Related]
10. Synthetic retinoid AM80 inhibits IL-17 production of gamma delta T cells and ameliorates biliary atresia in mice. Möhn N; Bruni E; Schröder A; Frömmel S; Gueler F; Vieten G; Prinz I; Kuebler JF; Petersen C; Klemann C Liver Int; 2020 Dec; 40(12):3031-3041. PubMed ID: 33463083 [TBL] [Abstract][Full Text] [Related]
11. A novel approach for systematic delivery of a hydrophobic anti-leukemia agent tamibarotene mediated by nanostructured lipid carrier. Liu X; Wang Z; Feng R; Hu Y; Huang G J Biomed Nanotechnol; 2013 Sep; 9(9):1586-93. PubMed ID: 23980506 [TBL] [Abstract][Full Text] [Related]
12. Synthetic retinoid Am80 up-regulates apelin expression by promoting interaction of RARα with KLF5 and Sp1 in vascular smooth muscle cells. Lv XR; Zheng B; Li SY; Han AL; Wang C; Shi JH; Zhang XH; Liu Y; Li YH; Wen JK Biochem J; 2013 Nov; 456(1):35-46. PubMed ID: 23992409 [TBL] [Abstract][Full Text] [Related]
13. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497 [TBL] [Abstract][Full Text] [Related]
14. Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis. Sanda T; Kuwano T; Nakao S; Iida S; Ishida T; Komatsu H; Shudo K; Kuwano M; Ono M; Ueda R Leukemia; 2005 Jun; 19(6):901-9. PubMed ID: 15843826 [TBL] [Abstract][Full Text] [Related]
15. Disturbance of rapid eye movement sleep in senescence-accelerated mouse prone/8 mice is improved by retinoic acid receptor agonist Am80 (Tamibarotene). Kitaoka K; Sano A; Chikahisa S; Yoshizaki K; Séi H Neuroscience; 2010 May; 167(3):573-82. PubMed ID: 20138974 [TBL] [Abstract][Full Text] [Related]
16. A retinoic acid receptor agonist Am80 rescues neurons, attenuates inflammatory reactions, and improves behavioral recovery after intracerebral hemorrhage in mice. Matsushita H; Hijioka M; Hisatsune A; Isohama Y; Shudo K; Katsuki H J Cereb Blood Flow Metab; 2011 Jan; 31(1):222-34. PubMed ID: 20551971 [TBL] [Abstract][Full Text] [Related]